{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:39:24Z","timestamp":1775705964255,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001794","name":"The University of Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12350-023-03345-w","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T16:29:26Z","timestamp":1692203366000},"page":"2676-2691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET\/CT and cardiac MRI"],"prefix":"10.1016","volume":"30","author":[{"given":"Evyn G.","family":"Arnfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Younger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Avinash","family":"Chikatamarla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wyld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Burge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Ladwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-023-03345-w_bib1","article-title":"The epidemiology of neuroendocrine tumors in Taiwan: A nation-wide cancer registry-based study","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1007\/s12350-023-03345-w_bib2","first-page":"124","article-title":"A single center experience of cardiac metastasis from neuroendocrine tumors (NET)","volume":"12","author":"Ladwa","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1007\/s12350-023-03345-w_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"10.1007\/s12350-023-03345-w_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7150\/jca.4502","article-title":"Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: A seer analysis","volume":"3","author":"Tsikitis","year":"2012","journal-title":"J Cancer"},{"key":"10.1007\/s12350-023-03345-w_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101598","article-title":"Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia","volume":"63","author":"Wyld","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"10.1007\/s12350-023-03345-w_bib6","first-page":"931","article-title":"Epidemiology of neuroendocrine cancers in an Australian population","volume":"21","author":"Luke","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1007\/s12350-023-03345-w_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MNM.0000000000000464","article-title":"Cardiac neuroendocrine tumour metastases: Case reports and review of the literature","volume":"37","author":"Bonsen","year":"2016","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-023-03345-w_bib8","first-page":"205","article-title":"Ga-68 DOTATATE PET\/CT: Is it appropriate to be used as a screening imaging modality in patients with raised biochemical markers and non-specific symptoms?","volume":"108","author":"Cox","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1007\/s12350-023-03345-w_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.109.066134","article-title":"The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy","volume":"51","author":"Srirajaskanthan","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-023-03345-w_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Radiological, nuclear medicine and hybrid imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1007\/s12350-023-03345-w_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: Clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"key":"10.1007\/s12350-023-03345-w_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000287277","article-title":"ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors","volume":"91","author":"Pavel","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1007\/s12350-023-03345-w_bib13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jcp.2004.016055","article-title":"Cardiac metastasis from a bronchial carcinoid: Report of a case presenting with diffuse thickening of the left ventricular wall","volume":"57","author":"Goddard","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1007\/s12350-023-03345-w_bib14","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1200\/JCO.2000.18.7.1596","article-title":"Case 2: Myocardial metastases from a carcinoid tumor","volume":"18","author":"Penz","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1007\/s12350-023-03345-w_bib15","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1097\/RLU.0000000000002944","article-title":"Cardiac metastases in neuroendocrine tumors: 68Ga-DOTATATE PET\/CT with cardiac magnetic resonance correlation","volume":"45","author":"Polk","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-023-03345-w_bib16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1159\/000510444","article-title":"Cardiac metastases in patients with neuroendocrine tumours: Clinical features, therapy outcomes, and prognostic implications","volume":"111","author":"Liu","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1007\/s12350-023-03345-w_bib17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.athoracsur.2015.03.073","article-title":"Surgical treatment of an isolated metastatic myocardial neuroendocrine tumor","volume":"101","author":"Caldeira","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1007\/s12350-023-03345-w_bib18","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(02)02109-5","article-title":"Metastatic carcinoid tumor to the heart: Echocardiographic-pathologic study of 11 patients","volume":"40","author":"Pandya","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-023-03345-w_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-012-2330-6","article-title":"The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours","volume":"40","author":"Zaknun","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-023-03345-w_bib20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1055\/s-0030-1267204","article-title":"A matter of the heart: Myocardial metastases in neuroendocrine tumors","volume":"42","author":"Jann","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1007\/s12350-023-03345-w_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.596921","article-title":"Case report: Neuroendocrine tumor with cardiac metastasis","volume":"7","author":"Kinney","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1007\/s12350-023-03345-w_bib22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/RLU.0000000000000963","article-title":"Cardiac metastases of neuroendocrine tumors treated with 177Lu DOTATATE peptide receptor radionuclide therapy or 131I-MIBG therapy","volume":"40","author":"Makis","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-023-03345-w_bib23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12350-018-1426-1","article-title":"Large cardiac metastasis from pancreatic neuroendocrine tumor and response to peptide receptor radionuclide therapy with 177Lu-DOTATATE","volume":"27","author":"Parghane","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-023-03345-w_bib24","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/RLU.0000000000003283","article-title":"The use of peptide receptor radionuclide therapy in patients with neuroendocrine tumor cardiac metastases","volume":"46","author":"Yu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-023-03345-w_bib25","article-title":"Cardiac magnetic resonance for diagnosis of neuroendocrine tumor metastases to the right and left ventricles with carcinoid heart disease","volume":"2019","author":"Barnebee","year":"2019","journal-title":"Case Rep Cardiol"},{"key":"10.1007\/s12350-023-03345-w_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcr\/yty096","article-title":"Solitary neuroendocrine carcinoma of the heart: A case report","author":"Wi\u00dft","year":"2018","journal-title":"Eur Heart J Case Rep"},{"key":"10.1007\/s12350-023-03345-w_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/1532-429X-10-14","article-title":"Imaging myocardial carcinoid with T2-STIR CMR","author":"Schiavone","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-023-03345-w_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.0004-8461.2004.01323.x","article-title":"Cardiac metastasis from carcinoid tumour: Magnetic resonance imaging findings","volume":"48","author":"Puvaneswary","year":"2004","journal-title":"Australas Radiol"},{"key":"10.1007\/s12350-023-03345-w_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1007\/s12350-023-03345-w_bib30","first-page":"S219","article-title":"Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-d-Phe1]-octreotide","volume":"31","author":"Krenning","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1007\/s12350-023-03345-w_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007829","article-title":"Assessment of cardiac masses by cardiac magnetic resonance imaging: Histological correlation and clinical outcomes","volume":"8","author":"Mousavi","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1007\/s12350-023-03345-w_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016391","article-title":"Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: A qualitative study","volume":"7","author":"Evans","year":"2017","journal-title":"BMJ Open"},{"key":"10.1007\/s12350-023-03345-w_bib33","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150121","article-title":"A comparison of the psychological burden of PET\/MRI and PET\/CT scans and association to initial state anxiety and previous imaging experiences","volume":"88","author":"Shortman","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1007\/s12350-023-03345-w_bib34","article-title":"Hybrid imaging of neuroendocrine tumors in the heart: Union is strength","author":"Marketou","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-023-03345-w_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40644-018-0168-2","article-title":"Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT","volume":"18","author":"Kunz","year":"2018","journal-title":"Cancer Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-023-03345-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-023-03345-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124002113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124002113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-023-03345-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:14:27Z","timestamp":1761027267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358124002113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1071358124002113"],"URL":"https:\/\/doi.org\/10.1007\/s12350-023-03345-w","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET\/CT and cardiac MRI","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-023-03345-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by ELSEVIER INC. on behalf of American Society of Nuclear Cardiology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}